JP2009073850A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009073850A5 JP2009073850A5 JP2008287205A JP2008287205A JP2009073850A5 JP 2009073850 A5 JP2009073850 A5 JP 2009073850A5 JP 2008287205 A JP2008287205 A JP 2008287205A JP 2008287205 A JP2008287205 A JP 2008287205A JP 2009073850 A5 JP2009073850 A5 JP 2009073850A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- weight
- isa
- polyoxyethylene
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 20
- 239000000203 mixture Substances 0.000 claims 12
- 239000012736 aqueous medium Substances 0.000 claims 9
- 239000004530 micro-emulsion Substances 0.000 claims 8
- 239000003921 oil Substances 0.000 claims 8
- 235000019198 oils Nutrition 0.000 claims 8
- 239000003814 drug Substances 0.000 claims 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 7
- 229920000053 polysorbate 80 Polymers 0.000 claims 7
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- -1 polyoxyethylene Polymers 0.000 claims 6
- 230000001506 immunosuppresive effect Effects 0.000 claims 5
- AOBORMOPSGHCAX-UHFFFAOYSA-N Tocophersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-UHFFFAOYSA-N 0.000 claims 4
- 235000015203 fruit juice Nutrition 0.000 claims 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims 4
- 229920000136 polysorbate Polymers 0.000 claims 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims 4
- 229930003231 vitamin Natural products 0.000 claims 4
- 229940088594 vitamin Drugs 0.000 claims 4
- 235000013343 vitamin Nutrition 0.000 claims 4
- 239000011782 vitamin Substances 0.000 claims 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims 4
- 206010062016 Immunosuppression Diseases 0.000 claims 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 2
- 244000269722 Thea sinensis Species 0.000 claims 2
- 244000299461 Theobroma cacao Species 0.000 claims 2
- 235000009470 Theobroma cacao Nutrition 0.000 claims 2
- 235000015197 apple juice Nutrition 0.000 claims 2
- 229920000249 biocompatible polymer Polymers 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 239000003995 emulsifying agent Substances 0.000 claims 2
- 230000002708 enhancing effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000001087 glyceryl triacetate Substances 0.000 claims 2
- 235000013773 glyceryl triacetate Nutrition 0.000 claims 2
- 235000015201 grapefruit juice Nutrition 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 230000002757 inflammatory effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000008267 milk Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000013616 tea Nutrition 0.000 claims 2
- 229960002622 triacetin Drugs 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 claims 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 claims 1
- 239000004606 Fillers/Extenders Substances 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- 229920001219 Polysorbate 40 Polymers 0.000 claims 1
- 229920001214 Polysorbate 60 Polymers 0.000 claims 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims 1
- 239000004147 Sorbitan trioleate Substances 0.000 claims 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 claims 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 229920001400 block copolymer Polymers 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 239000007903 gelatin capsule Substances 0.000 claims 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000008389 polyethoxylated castor oil Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 229940035044 sorbitan monolaurate Drugs 0.000 claims 1
- 235000011076 sorbitan monostearate Nutrition 0.000 claims 1
- 239000001587 sorbitan monostearate Substances 0.000 claims 1
- 229940035048 sorbitan monostearate Drugs 0.000 claims 1
- 235000019337 sorbitan trioleate Nutrition 0.000 claims 1
- 229960000391 sorbitan trioleate Drugs 0.000 claims 1
- 235000011078 sorbitan tristearate Nutrition 0.000 claims 1
- 239000001589 sorbitan tristearate Substances 0.000 claims 1
- 229960004129 sorbitan tristearate Drugs 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34620101P | 2001-10-19 | 2001-10-19 | |
| US37059702P | 2002-04-05 | 2002-04-05 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535753A Division JP2005506990A (ja) | 2001-10-19 | 2002-10-17 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012118377A Division JP2012158609A (ja) | 2001-10-19 | 2012-05-24 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009073850A JP2009073850A (ja) | 2009-04-09 |
| JP2009073850A5 true JP2009073850A5 (enExample) | 2009-05-21 |
Family
ID=26994747
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535753A Pending JP2005506990A (ja) | 2001-10-19 | 2002-10-17 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
| JP2008287205A Pending JP2009073850A (ja) | 2001-10-19 | 2008-11-07 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
| JP2012118377A Pending JP2012158609A (ja) | 2001-10-19 | 2012-05-24 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003535753A Pending JP2005506990A (ja) | 2001-10-19 | 2002-10-17 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012118377A Pending JP2012158609A (ja) | 2001-10-19 | 2012-05-24 | 新規のシクロスポリン類似体のマイクロエマルションプレコンセントレート |
Country Status (28)
| Country | Link |
|---|---|
| US (5) | US7060672B2 (enExample) |
| EP (2) | EP1435910B9 (enExample) |
| JP (3) | JP2005506990A (enExample) |
| KR (1) | KR100978836B1 (enExample) |
| CN (1) | CN1274294C (enExample) |
| AR (1) | AR036852A1 (enExample) |
| AT (1) | ATE437629T1 (enExample) |
| AU (1) | AU2002333098B2 (enExample) |
| BR (1) | BR0213661A (enExample) |
| CA (1) | CA2461730C (enExample) |
| CO (1) | CO5580835A2 (enExample) |
| DE (1) | DE60233150D1 (enExample) |
| DK (1) | DK1435910T3 (enExample) |
| ES (1) | ES2330625T3 (enExample) |
| HR (1) | HRP20040354B1 (enExample) |
| IL (3) | IL160761A0 (enExample) |
| MA (1) | MA26221A1 (enExample) |
| ME (1) | MEP89008A (enExample) |
| MX (1) | MXPA04003623A (enExample) |
| MY (1) | MY145753A (enExample) |
| NO (1) | NO20042028L (enExample) |
| NZ (1) | NZ531946A (enExample) |
| PL (1) | PL206018B1 (enExample) |
| PT (1) | PT1435910E (enExample) |
| RU (1) | RU2317067C2 (enExample) |
| TN (1) | TNSN04070A1 (enExample) |
| WO (1) | WO2003032949A1 (enExample) |
| ZA (1) | ZA200402268B (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL206018B1 (pl) * | 2001-10-19 | 2010-06-30 | Isotechnika Inc | Preparat farmaceutyczny, sposób jego wytwarzania, mikroemulsja i zastosowanie tego preparatu farmaceutycznego |
| JP2006524232A (ja) | 2003-03-17 | 2006-10-26 | アルバニー モレキュラー リサーチ インコーポレーティッド | 新規サイクロスポリン |
| GB0307440D0 (en) * | 2003-03-31 | 2003-05-07 | Novartis Ag | Organic compounds |
| US20050256097A1 (en) * | 2004-05-11 | 2005-11-17 | Kosan Biosciences, Inc. | Pharmaceutical solution formulations containing 17-AAG |
| WO2006039164A2 (en) | 2004-09-29 | 2006-04-13 | Amr Technology, Inc. | Novel cyclosporin analogues and their pharmaceutical uses |
| EP1809656A4 (en) * | 2004-09-29 | 2009-03-25 | Amr Technology Inc | CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS |
| US7361636B2 (en) | 2004-10-06 | 2008-04-22 | Amr Technology, Inc. | Cyclosporin alkynes and their utility as pharmaceutical agents |
| WO2008121096A1 (en) * | 2005-05-19 | 2008-10-09 | The Board Of Governors For Higher Education | Monitoring cyclosporine in saliva |
| CA2645080A1 (en) * | 2006-03-07 | 2007-09-13 | Novavax,Inc. | Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same |
| US10137083B2 (en) * | 2006-03-07 | 2018-11-27 | SGN Nanopharma Inc | Ophthalmic preparations |
| US11311477B2 (en) | 2006-03-07 | 2022-04-26 | Sgn Nanopharma Inc. | Ophthalmic preparations |
| US7696165B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders |
| US7696166B2 (en) * | 2006-03-28 | 2010-04-13 | Albany Molecular Research, Inc. | Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders |
| EP2104498A2 (en) * | 2006-10-31 | 2009-09-30 | Wyeth | Liquid formulations of phospholipase enzyme inhibitors |
| BRPI0718030A2 (pt) * | 2006-10-31 | 2013-11-12 | Wyeth Corp | Formulações de inibidores de enzima de fosfolipase |
| JP5668476B2 (ja) * | 2007-10-08 | 2015-02-12 | オーリニア・ファーマシューティカルズ・インコーポレイテッドＡｕｒｉｎｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | カルシニューリン阻害剤またはｍＴＯＲ阻害剤を含む眼科用組成物 |
| MX2010010050A (es) | 2008-03-20 | 2011-03-15 | Virun Inc Star | Emulsiones que incluyen un derivado de polietilen glicol de tocoferol. |
| CA2715018C (en) * | 2008-03-20 | 2012-11-13 | Virun, Inc. | Vitamin e derivatives and their uses |
| US8252821B2 (en) * | 2009-04-14 | 2012-08-28 | Bristol-Myers Squibb Company | Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compound |
| WO2010144194A1 (en) | 2009-06-09 | 2010-12-16 | Lux Biosciences, Inc. | Topical drug delivery systems for ophthalmic use |
| CN102652015B (zh) | 2009-12-10 | 2016-08-03 | 默克专利有限公司 | 包含寡肽、优选西仑吉肽的药物组合物 |
| CN103037708B (zh) * | 2010-03-23 | 2015-05-20 | 维尔恩公司 | 含有蔗糖脂肪酸酯的纳米乳液 |
| IT1404931B1 (it) * | 2010-06-11 | 2013-12-09 | Medivis S R L | Composizioni oftalmiche per la somministrazione di principi attivi liposolubili . |
| WO2011162802A1 (en) | 2010-06-21 | 2011-12-29 | Virun, Inc. | Compositions containing non-polar compounds |
| US20110319467A1 (en) * | 2010-06-23 | 2011-12-29 | Bhiku Patel | Absorption Enhancement of Statins and Omega Fatty Acids |
| RU2566984C2 (ru) * | 2010-06-25 | 2015-10-27 | Фирмениш Са | Система доставки пищевых компонентов |
| US9044394B2 (en) * | 2010-10-18 | 2015-06-02 | PruGen IP Holdings, Inc. | Bioavailability enhancement delivery composition |
| US20120095098A1 (en) * | 2010-10-18 | 2012-04-19 | Bhiku Patel | Bioavailability Enhancement Delivery System |
| HRP20190096T1 (hr) | 2010-12-15 | 2019-02-22 | Contravir Pharmaceuticals, Inc. | Molekule analoga ciklosporina modificirani na amino kiselini 1 i 3 |
| WO2013090461A1 (en) * | 2011-12-12 | 2013-06-20 | PruGen IP Holdings, Inc. | Statin bioavailability enhancement delivery composition |
| US8609684B2 (en) | 2011-12-12 | 2013-12-17 | PruGen IP Holdings, Inc. | Solubilization and bioavailability of acetaminophen |
| SI2887923T1 (sl) | 2012-08-24 | 2023-09-29 | Sun Pharmaceutical Industries Limited | Oftalmična formulacija polioksilnega lipida ali polioksilne maščobne kisline in zdravljenje očesnih stanj |
| GB201222455D0 (en) * | 2012-12-13 | 2013-01-30 | Perioc Ltd | Novel pharmaceutical formulations and their use in the treatment of periodontaldisease |
| US9351517B2 (en) | 2013-03-15 | 2016-05-31 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and compositions containing same |
| CA2942186C (en) | 2014-06-18 | 2023-06-27 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising non-ionic surfactants |
| US9861611B2 (en) | 2014-09-18 | 2018-01-09 | Virun, Inc. | Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same |
| FI3373976T3 (fi) | 2015-11-10 | 2024-03-25 | Sun Pharmaceutical Ind Ltd | Topikaalisia formulaatioita ja niiden käyttöjä |
| WO2017151657A1 (en) | 2016-02-29 | 2017-09-08 | Ocular Technologies Sarl | Topical cyclosporine-containing formulations and uses thereof |
| US20200003785A1 (en) | 2016-12-01 | 2020-01-02 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Use of anti-uchl1 igg plasma concentration for diagnosing idiopathic steroid sensitive nephrotic syndrome |
| US20190224275A1 (en) | 2017-05-12 | 2019-07-25 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| US10286036B2 (en) | 2017-05-12 | 2019-05-14 | Aurinia Pharmaceuticals Inc. | Protocol for treatment of lupus nephritis |
| WO2019077123A1 (en) | 2017-10-20 | 2019-04-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | METHODS AND KITS FOR IDENTIFYING WHETHER A SUBJECT IS REACHED OR RISK OF BEING WITH AUTOIMMUNE MYOPATHY |
| LT3886813T (lt) * | 2018-11-26 | 2023-04-11 | Hepion Pharmaceuticals, Inc. | Farmacinės ciklosporino analogų formos |
| US20220018835A1 (en) | 2018-12-07 | 2022-01-20 | INSERM (Institut National de la Santé et de la Recherche Médicale | Use of cd26 and cd39 as new phenotypic markers for assessing maturation of foxp3+ t cells and uses thereof for diagnostic purposes |
| WO2020148338A1 (en) | 2019-01-15 | 2020-07-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Mutated interleukin-34 (il-34) polypeptides and uses thereof in therapy |
| JP7494163B2 (ja) | 2019-03-27 | 2024-06-03 | 学校法人東京医科大学 | ウォルフラム症候群の治療剤 |
| WO2021224890A1 (en) | 2020-05-07 | 2021-11-11 | Aurinia Pharmaceuticals Inc. | Methods of treating or preventing coronavirus infection |
| KR102449537B1 (ko) * | 2022-01-27 | 2022-10-05 | 주식회사 나노메디팜 | 근적외선을 이용하여 진단 생검 또는 종양 제거 수술 중에 종양 식별과 절제면 구분을 위한 종양 표적 진단 조영제 |
| WO2024153636A1 (en) | 2023-01-17 | 2024-07-25 | Institut National de la Santé et de la Recherche Médicale | Vasorin as a biomarker and biotarget in nephrology |
| WO2025021782A1 (en) | 2023-07-24 | 2025-01-30 | Institut National de la Santé et de la Recherche Médicale | Methods of determining whether a subject suffering from lupus nephritis (ln) will achieve a response with an induction therapy |
| WO2025045894A1 (en) | 2023-08-28 | 2025-03-06 | Institut National de la Santé et de la Recherche Médicale | Methods and kits for diagnosing cause of nephrotic syndrome and guiding therapy |
Family Cites Families (134)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH614931A5 (enExample) | 1975-11-04 | 1979-12-28 | Sandoz Ag | |
| DE2819094A1 (de) | 1977-05-10 | 1978-11-23 | Sandoz Ag | Cyclosporin-derivate, ihre verwendung und herstellung |
| DE2907460A1 (de) | 1978-03-07 | 1979-09-13 | Sandoz Ag | Neue resorbierbare galenische kompositionen |
| CH641356A5 (en) | 1979-02-27 | 1984-02-29 | Sandoz Ag | Pharmaceutical compositions containing cyclosporin |
| US4384996A (en) | 1981-01-09 | 1983-05-24 | Sandoz Ltd. | Novel cyclosporins |
| CH667274A5 (de) | 1984-03-23 | 1988-09-30 | Sandoz Ag | Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen. |
| US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| GB8903804D0 (en) | 1989-02-20 | 1989-04-05 | Sandoz Ltd | Improvements in or relating to organic compounds |
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| US4764503A (en) | 1986-11-19 | 1988-08-16 | Sandoz Ltd. | Novel cyclosporins |
| NL194638C (nl) | 1986-12-19 | 2002-10-04 | Novartis Ag | Hydrosol die vaste deeltjes van een farmaceutisch actieve stof bevat en farmaceutisch preparaat dat deze hydrosol bevat. |
| JP2577049B2 (ja) | 1987-06-04 | 1997-01-29 | 三共株式会社 | シクロスポリン製剤 |
| DE3884470T2 (de) | 1987-06-17 | 1994-03-10 | Sandoz Ag | Cyclosporine und deren Benutzung als Arzneimittel. |
| DE3851268T2 (de) | 1987-06-19 | 1995-01-26 | Sandoz Ag | Zyklische Peptolide. |
| DE3830494B4 (de) | 1987-09-15 | 2006-05-18 | Novartis Ag | Wasserlösliche Monoester als Solubilisatoren für pharmakologische Wirkstoffe und pharmazeutische Hilfsstoffe |
| DE68900991D1 (de) | 1988-01-29 | 1992-04-23 | Sankyo Co | Cyclosporin-zusammensetzungen. |
| HU201567B (en) | 1988-07-21 | 1990-11-28 | Gyogyszerkutato Intezet | Process for production of intravenous medical compositions containing cyclosphorin |
| JP2792862B2 (ja) | 1988-07-30 | 1998-09-03 | 寛治 高田 | 経口腸溶製剤 |
| US5350741A (en) | 1988-07-30 | 1994-09-27 | Kanji Takada | Enteric formulations of physiologically active peptides and proteins |
| US6007840A (en) | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
| US5342625A (en) | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
| KR0148748B1 (ko) | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
| GB8823621D0 (en) | 1988-10-07 | 1988-11-16 | Madhok R | Compositions containing cyclosporins |
| DE3843241A1 (de) | 1988-12-22 | 1990-06-28 | Skrezek Christian | Nephroprotektive infusionsloesung |
| GB2230440B (en) | 1989-02-09 | 1993-05-19 | Sandoz Ltd | Novel cyclosporin galenic forms |
| US5540931A (en) | 1989-03-03 | 1996-07-30 | Charles W. Hewitt | Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants |
| US4996193A (en) | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
| US5284826A (en) | 1989-07-24 | 1994-02-08 | Sandoz Ltd. | 0-hydroxyethyl and acyloxyethyl derivatives of [ser]8 cyclosporins |
| US5356633A (en) | 1989-10-20 | 1994-10-18 | Liposome Technology, Inc. | Method of treatment of inflamed tissues |
| US5681964A (en) | 1990-10-23 | 1997-10-28 | University Of Kentucky Research Foundation | Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents |
| DE69124459T3 (de) | 1990-11-02 | 2001-05-31 | Novartis Ag, Basel | Zyklosporine |
| GB9105705D0 (en) | 1991-03-18 | 1991-05-01 | Sandoz Ltd | Improvements in or relating to organic compounds |
| EP0580817B1 (en) | 1991-04-19 | 1996-06-19 | NeXstar Pharmaceuticals, Inc. | Pharmaceutical formulation and process |
| US5620971A (en) | 1991-05-09 | 1997-04-15 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
| GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
| US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
| US5248499A (en) | 1991-10-07 | 1993-09-28 | Genentech, Inc. | Control of microbial infections in transplant patients |
| GB9203886D0 (en) | 1992-02-24 | 1992-04-08 | Sandoz Ltd | Improvements in or relating to organic compounds |
| GB9208712D0 (en) | 1992-04-22 | 1992-06-10 | Sandoz Ltd | Pharmaceutical compositions containing cyclosporin derivates |
| US5654000A (en) | 1992-07-28 | 1997-08-05 | Poli Industria Chimica S.P.A. | Pharmaceutical compositions for transmucosal delivery of peptides |
| US5759566A (en) | 1992-07-28 | 1998-06-02 | Poli Industria Chimica Spa | Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents |
| SK277092A3 (en) | 1992-09-07 | 1996-08-07 | Galena As | Medicaments with n-methylated cyclic undecapeptides |
| ES2168271T3 (es) | 1992-09-25 | 2002-06-16 | Novartis Ag | Composiciones farmaceuticas que contienen ciclosporinas. |
| WO1994008605A1 (en) | 1992-10-16 | 1994-04-28 | Smithkline Beecham Corporation | Therapeutic microemulsions |
| WO1994008603A1 (en) | 1992-10-16 | 1994-04-28 | Smithkline Beecham Corporation | Compositions |
| JPH08504811A (ja) | 1992-12-24 | 1996-05-28 | ヘマジェン／ピーエフシー | フルオロカーボンのエマルジョン |
| US6113921A (en) | 1993-03-23 | 2000-09-05 | Pharmos Corp. | Topical and transdermal delivery system utilizing submicron oil spheres |
| NZ247516A (en) | 1993-04-28 | 1995-02-24 | Bernard Charles Sherman | Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant |
| CH686761A5 (de) | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
| US5639474A (en) | 1993-07-01 | 1997-06-17 | Hanmi Pharm. Ind., Ltd. | Cyclosporin soft capsule composition |
| CN1077800C (zh) | 1993-07-01 | 2002-01-16 | 韩美药品工业株式会社 | 环孢菌素软胶囊组合物 |
| DE69426408T2 (de) | 1993-09-28 | 2001-07-12 | Novartis Ag, Basel | Herstellung von Weichgelatinekapseln |
| US5840707A (en) | 1993-10-04 | 1998-11-24 | Albany Medical College | Stabilizing and delivery means of biological molecules |
| US6022852A (en) | 1993-10-22 | 2000-02-08 | Hexal Ag | Pharmaceutical composition containing cyclosporin A |
| US5567592A (en) | 1994-02-02 | 1996-10-22 | Regents Of The University Of California | Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal |
| EP0694308A4 (en) | 1994-02-17 | 1997-09-10 | Shiseido Co Ltd | CYCLOSPORIN EMULSION COMPOSITION |
| JP4157969B2 (ja) | 1994-03-18 | 2008-10-01 | スパーナス ファーマシューティカルズ インコーポレイテッド | 乳化薬物送達システム |
| US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
| FI100692B (fi) | 1994-05-24 | 1998-02-13 | Leiras Oy | Menetelmä farmaseuttisten koostumusten valmistamiseksi, jolloin koostu mukset pohjautuvat mikroemulsiogeeleihin sekä uusia mikroemulsioihin p ohjautuvia geelejä |
| RU2119351C1 (ru) | 1994-06-01 | 1998-09-27 | Юхан Корпорейшн | Иммуносупрессорная композиция, содержащая циклоспорин, и способ ее получения |
| CH686865A5 (de) | 1994-06-15 | 1996-07-31 | Gergely Gerhard | Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung. |
| EP0697214A1 (en) | 1994-07-19 | 1996-02-21 | Vestar, Inc. | Liposomal cyclosporin pharmaceutical formulations |
| EP0769936A1 (en) | 1994-07-22 | 1997-05-02 | G.D. Searle & Co. | Self-emulsifying drug delivery system |
| US5635159A (en) | 1994-08-26 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing polyglycolyzed glycerides |
| IL129547A (en) | 1994-10-26 | 2001-01-11 | Novartis Ag | Pharmaceutical compositions comprising a macrolide and an acid |
| US5603951A (en) | 1994-11-09 | 1997-02-18 | Hanmi Pharm. Ind. Co., Ltd. | Cyclosporin-containing soft capsule compositions |
| HU215966B (hu) * | 1994-11-21 | 1999-07-28 | BIOGAL Gyógyszergyár Rt. | Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum |
| KR0167613B1 (ko) * | 1994-12-28 | 1999-01-15 | 한스 루돌프 하우스, 니콜 케르커 | 사이클로스포린-함유 연질캅셀제 조성물 |
| KR100239799B1 (ko) | 1995-01-21 | 2000-02-01 | 손경식 | 경구투여용 사이클로스포린 에이 고체미셀분산체, 이의 제조 방법 및 고형제제 |
| GB9512100D0 (en) | 1995-06-14 | 1995-08-09 | Sandoz Nutrition Ltd | Improvements in or relating to organic compounds |
| IE75744B1 (en) | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
| AU692255B2 (en) | 1995-04-24 | 1998-06-04 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Self-emulsifiable formulation producing an oil-in-water emulsion |
| CA2221145A1 (en) | 1995-05-19 | 1996-11-21 | Abbott Laboratories | Self-emulsifying formulations of lipophilic drugs |
| US5693336A (en) | 1995-06-07 | 1997-12-02 | Nexstar Pharmaceuticals, Inc. | Blood stable liposomal cyclosporin formulations |
| US5635161A (en) | 1995-06-07 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing vegetable oils |
| US5656287A (en) | 1995-06-07 | 1997-08-12 | Nexstar Pharmaceuticals, Inc. | Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications |
| DE19521974A1 (de) | 1995-06-16 | 1996-12-19 | Hexal Pharmaforschung Gmbh | Pharmazeutische Zubereitung mit Cyclosporin A |
| IL120673A0 (en) | 1995-08-25 | 1997-08-14 | Sangstat Medical Corp | Oral cyclosporin formulations |
| US5834017A (en) | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
| US5962019A (en) | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
| US5827822A (en) | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
| EP0760237A1 (en) | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
| NZ280689A (en) | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
| CZ288631B6 (cs) | 1996-01-18 | 2001-08-15 | Galena, A. S. | Léčivé přípravky s obsahem cyklosporinu |
| KR970064620A (ko) | 1996-03-05 | 1997-10-13 | 임성기 | 사이클로스포린-함유 외용약제 조성물 |
| EP0944394A4 (en) | 1996-03-12 | 2003-05-14 | Picower Inst Med Res | TREATING HIV INFECTION BY INFLUENCING CYCLOPHILIN RECEPTOR ACTIVITY IN THE HOST CELL |
| US5660858A (en) | 1996-04-03 | 1997-08-26 | Research Triangle Pharmaceuticals | Cyclosporin emulsions |
| ID18663A (id) | 1996-04-12 | 1998-04-30 | Novartis Ag | Komposisi farmasi berlapis enterik |
| CA2240705C (en) | 1996-06-19 | 2007-07-31 | Novartis Ag | Cyclosporin-containing soft capsule preparations |
| US5958876A (en) | 1996-06-19 | 1999-09-28 | Novartis Ag | Cyclosporin-containing pharmaceutical compositions |
| KR980008239A (ko) | 1996-07-26 | 1998-04-30 | 김충환 | 사이클로스포린-함유 약학적 조성물 |
| WO1998004279A1 (en) | 1996-07-30 | 1998-02-05 | Novartis Ag | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| CZ288739B6 (cs) | 1996-08-01 | 2001-08-15 | Galena, A. S. | Cyklosporin obsahující léčivé přípravky |
| CZ267796A3 (cs) | 1996-09-12 | 1998-04-15 | Galena A.S. | Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů |
| CA2185600A1 (en) | 1996-09-16 | 1998-03-17 | Bernard Charles Sherman | Water-soluble concentrates containing cyclosporins |
| US5798333A (en) | 1996-09-17 | 1998-08-25 | Sherman; Bernard C. | Water-soluble concentrates containing cyclosporins |
| FR2757521B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| FR2757520B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
| FR2757522B1 (fr) | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| NZ314060A (en) | 1997-01-13 | 1997-08-22 | Bernard Charles Sherman | Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s) |
| TR199901686T2 (xx) | 1997-01-30 | 1999-09-21 | Norvartis Ag | Esasen ya�s�z farmakolojik kompozisyonlar� i�eren sert jelatin kaps�ller. |
| US6306434B1 (en) | 1997-02-12 | 2001-10-23 | Chong Kun Dang Corp. | Pharmaceutical composition comprising cyclosporin solid-state microemulsion |
| EP0979647A4 (en) | 1997-02-27 | 2006-07-19 | Nippon Shinyaku Co Ltd | FAT EMULSION FOR ORAL ADMINISTRATION |
| HU228855B1 (en) | 1997-03-12 | 2013-06-28 | Abbott Lab | Hydrophilic binary systems for the administration of cyclosporine |
| NZ314702A (en) | 1997-04-29 | 1998-07-28 | Bernard Charles Sherman | Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent |
| CA2285983A1 (en) | 1997-04-29 | 1998-11-05 | Bernard Charles Sherman | Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride |
| FR2762843B1 (fr) | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| IN188719B (enExample) | 1997-09-08 | 2002-11-02 | Panacea Biotec Ltd | |
| US6008191A (en) | 1997-09-08 | 1999-12-28 | Panacea Biotec Limited | Pharmaceutical compositions containing cyclosporin |
| US6187747B1 (en) | 1997-09-08 | 2001-02-13 | Panacea Biotech Limited | Pharmaceutical composition comprising cyclosporin |
| US6346511B1 (en) | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
| DE69816778T2 (de) * | 1997-09-09 | 2004-04-15 | Lyotropic Therapeutics, Inc. | Beschichtete teilchen, methode zu ihrer herstellung und verwendung |
| NZ328751A (en) | 1997-09-16 | 1999-01-28 | Bernard Charles Sherman | Solid medicament containing an anionic surfactant and cyclosporin |
| DE69840586D1 (de) * | 1997-10-08 | 2009-04-02 | Isotechnika Inc | Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien |
| UA65587C2 (en) | 1997-10-09 | 2004-04-15 | Baker Norton Pharma | Method for preventing nephrotoxicity induced by cyclosporins or tacrolimus |
| US5891845A (en) | 1997-11-21 | 1999-04-06 | Fuisz Technologies Ltd. | Drug delivery systems utilizing liquid crystal structures |
| US6063762A (en) * | 1997-12-05 | 2000-05-16 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
| US6028067A (en) | 1997-12-05 | 2000-02-22 | Chong Kun Dang Corp. | Cyclosporin-containing microemulsion preconcentrate composition |
| KR100587551B1 (ko) | 1997-12-10 | 2006-06-08 | 싸이클로스포린 테라퓨틱스 리미티드 | 오메가-3 지방산 오일을 함유하는 약학 조성물 |
| US20030216303A1 (en) * | 1998-03-06 | 2003-11-20 | Michael Ambuhl | Emulsion preconcentrates containing cyclosporin or a macrolide |
| DE19810655A1 (de) | 1998-03-12 | 1999-09-16 | Univ Eberhard Karls | Arzneimittel mit einem Gehalt an Ciclosporin |
| PT982035E (pt) | 1998-08-18 | 2004-08-31 | Panacea Biotec Ltd | Composicao de ciclosporina compreendendo um veiculo hidrofilo |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| ATE296091T1 (de) * | 1999-09-21 | 2005-06-15 | Skyepharma Canada Inc | Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe |
| AU7638200A (en) * | 1999-10-20 | 2001-04-30 | Vesifact Ag | Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions |
| JP2001122779A (ja) | 1999-10-26 | 2001-05-08 | Toyo Capsule Kk | 経口投与用シクロスポリン含有ミクロエマルジョン濃縮液 |
| JP2001240558A (ja) | 2000-02-29 | 2001-09-04 | Nippon Suisan Kaisha Ltd | 多価不飽和脂肪酸を経粘膜吸収促進剤として含有する固形製剤。 |
| DE10015463B4 (de) | 2000-03-29 | 2008-01-10 | Heide, Peter Edgar, Dr. | Creme in Form einer überwässerten Wasser-in-Öl-Emulsion |
| PT1151755E (pt) | 2000-05-04 | 2005-05-31 | Panacea Biotec Ltd | Composicoes farmaceuticas compreendendo a ciclosporina como substancia activa |
| AU2001261738A1 (en) | 2000-05-17 | 2001-11-26 | London Health Sciences Centre | Compositions and methods for promoting immunosuppression |
| DE10029404B4 (de) | 2000-06-15 | 2009-10-29 | Jagotec Ag | Arzneiformulierung enthaltend Ciclosporin und deren Verwendung |
| US6740636B2 (en) | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| PL206018B1 (pl) * | 2001-10-19 | 2010-06-30 | Isotechnika Inc | Preparat farmaceutyczny, sposób jego wytwarzania, mikroemulsja i zastosowanie tego preparatu farmaceutycznego |
-
2002
- 2002-10-17 PL PL370560A patent/PL206018B1/pl unknown
- 2002-10-17 NZ NZ531946A patent/NZ531946A/en not_active IP Right Cessation
- 2002-10-17 ME MEP-890/08A patent/MEP89008A/xx unknown
- 2002-10-17 AT AT02801263T patent/ATE437629T1/de active
- 2002-10-17 US US10/274,419 patent/US7060672B2/en not_active Expired - Lifetime
- 2002-10-17 RU RU2004110936/15A patent/RU2317067C2/ru not_active IP Right Cessation
- 2002-10-17 JP JP2003535753A patent/JP2005506990A/ja active Pending
- 2002-10-17 EP EP02801263A patent/EP1435910B9/en not_active Expired - Lifetime
- 2002-10-17 DE DE60233150T patent/DE60233150D1/de not_active Expired - Lifetime
- 2002-10-17 HR HRP20040354AA patent/HRP20040354B1/hr not_active IP Right Cessation
- 2002-10-17 MX MXPA04003623A patent/MXPA04003623A/es active IP Right Grant
- 2002-10-17 MY MYPI20023883A patent/MY145753A/en unknown
- 2002-10-17 EP EP09166128A patent/EP2116228A1/en not_active Withdrawn
- 2002-10-17 ES ES02801263T patent/ES2330625T3/es not_active Expired - Lifetime
- 2002-10-17 CA CA2461730A patent/CA2461730C/en not_active Expired - Lifetime
- 2002-10-17 AU AU2002333098A patent/AU2002333098B2/en not_active Ceased
- 2002-10-17 CN CNB02820641XA patent/CN1274294C/zh not_active Expired - Lifetime
- 2002-10-17 DK DK02801263T patent/DK1435910T3/da active
- 2002-10-17 IL IL16076102A patent/IL160761A0/xx unknown
- 2002-10-17 AR ARP020103917A patent/AR036852A1/es not_active Application Discontinuation
- 2002-10-17 BR BR0213661-9A patent/BR0213661A/pt not_active IP Right Cessation
- 2002-10-17 PT PT02801263T patent/PT1435910E/pt unknown
- 2002-10-17 WO PCT/CA2002/001561 patent/WO2003032949A1/en not_active Ceased
- 2002-10-17 KR KR1020047005700A patent/KR100978836B1/ko not_active Expired - Fee Related
-
2004
- 2004-03-05 IL IL160761A patent/IL160761A/en active IP Right Grant
- 2004-03-23 ZA ZA2004/02268A patent/ZA200402268B/en unknown
- 2004-03-26 MA MA27599A patent/MA26221A1/fr unknown
- 2004-04-16 TN TNP2004000070A patent/TNSN04070A1/en unknown
- 2004-04-19 CO CO04035664A patent/CO5580835A2/es not_active Application Discontinuation
- 2004-05-14 NO NO20042028A patent/NO20042028L/no not_active Application Discontinuation
-
2006
- 2006-03-13 US US11/375,532 patent/US7429562B2/en not_active Expired - Lifetime
-
2008
- 2008-08-22 US US12/197,199 patent/US7829533B2/en not_active Expired - Lifetime
- 2008-11-07 JP JP2008287205A patent/JP2009073850A/ja active Pending
- 2008-12-11 IL IL195892A patent/IL195892A/en active IP Right Grant
-
2010
- 2010-11-08 US US12/941,907 patent/US20110136744A1/en not_active Abandoned
-
2012
- 2012-05-24 JP JP2012118377A patent/JP2012158609A/ja active Pending
-
2014
- 2014-03-09 US US14/201,872 patent/US20140249092A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009073850A5 (enExample) | ||
| US11819491B2 (en) | Dilutable formulations of cannabinoids and processes for their preparation | |
| RU2004110936A (ru) | Микроэмульсионный предконцентрат аналога циклоспорина | |
| JP6920197B2 (ja) | 親油性活性剤を注入された飲食料品組成物とその使用方法 | |
| JP6419891B2 (ja) | ω３脂肪酸の自己乳化組成物 | |
| JP6978392B2 (ja) | トコトリエノールの経粘膜送達 | |
| CN102088970B (zh) | 用含槲皮素的组合物在制备改善肾功能的药物中的应用 | |
| AU2015266897A1 (en) | Stable cannabinoid formulations | |
| CN108430233A (zh) | 包含亲脂性活性剂的稳定的即饮型饮料组合物 | |
| RU2530769C2 (ru) | Снижение уровней холестерина путем совместного применения кверцетина и статина | |
| AU2016324349A1 (en) | Ubiquinone and ubiquinol compositions, and methods relating thereto | |
| CA2690490C (en) | Pharmaceutical formulations of loratadine for encapsulation and combinations thereof | |
| KR102477252B1 (ko) | 조현병 관련 정신 장애의 예방 또는 치료용 조성물 | |
| EP1864659B1 (en) | Lignane compound-containing oil-in-water emulsion and composition comprising the same | |
| KR20140016926A (ko) | 활성제로서 페닐아미노피리미딘 유도체를 포함하는 제제 | |
| JP2008532967A5 (enExample) | ||
| CN110882245A (zh) | 一种改善睡眠的组合物及其用途 | |
| WO2006003909A1 (ja) | 脂肪燃焼促進剤 | |
| CN105596499A (zh) | 一种具有解酒作用的组合物及其制备方法与应用 | |
| CN120583936A (zh) | 褪黑素液体制剂 | |
| CN103859395A (zh) | 一种高吸收率的辅酶q10的自乳化释药体系及其制备方法及应用 | |
| KR101693730B1 (ko) | 폴리코사놀 함유 수성 조성물 | |
| WO1995029677A1 (en) | Lactone stable formulation of camptothecin or 7-ethyl camptothecin | |
| US20230285288A1 (en) | Nanoparticle compositions comprising cannabinoids | |
| CN111565721A (zh) | 具有增强的生物利用度的包含依鲁替尼和生物碱的组合物 |